Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
 EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

Volume 10, Number 9, September 2004

SARS Antibody Test for Serosurveillance

Po-Ren Hsueh,* Chuan-Liang Kao,* Chun-Nan Lee,* Li-Kuan Chen,† Mei-Shang Ho,‡ Charles Sia,§¶ Xin De Fang,§ Shugene Lynn,¶ Tseng Yuan Chang,§ Shi Kau Liu,§ Alan M. Walfield,§ and Chang Yi Wang§¶
*National Taiwan University College of Medicine, Taipei, Taiwan; †Tsu Chi University, Hualien, Taiwan; ‡Academia Sinica, Taipei, Taiwan; §United Biomedical, Inc., Hauppauge, New York, USA; and ¶United Biomedical, Inc. Asia, Hsin Chu, Taiwan

 
 
Figure 1.
  Back to article
 

Figure 1. Distribution of tested specimens. Signal/cutoff (S/C) distribution of Center for Disease Control (Taiwan) SARS (severe acute respiratory syndrome) serum panel and blood donor serum panel. The mean signal/cutoff (S/C) ratio for the SARS samples was 8.08. The mean S/C for the 1,390 normal human plasma was 0.28.

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed August 18, 2004

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention